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Abstract 
ATP is an important inflammatory and vasoactive mediator, which acts via two 
receptor classes; P2X and P2Y. Activation of P2X receptors has traditionally been 
associated with the well-characterised vasoconstrictor properties of ATP. In the current 
study, we have used classical bioassay to show that the P2X receptor ligand, ,  
methylene ATP induces vasodilatation of rat isolated mesenteric arteries. Second order 
rat mesenteric arteries were mounted in myographs and vasomotor responses recorded. 
Both ATP and ,  methylene ATP induced a constriction followed by a vasodilation. 
The dilator effects of either ATP or ,  methylene ATP was slower in onset that that 
induced by acetylcholine. Vasodilation induced by ,  methylene ATP was endothelial 
cell dependent and characterised as mediated predominately by EDHF release. These 
results show for the first time, that P2X receptor activation results in endothelial 
dependent vasodilatation. These observations have important implications for our 
understanding of the role of purines in biological responses.       
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Introduction 
 ATP is an important mediator in the cardiovascular system. It is released by 
platelets, vascular and cardiac cells in response to common receptor-mediated ligands 
(Yang et al., 1994), physical forces and after ischemia-reperfusion (Burnstock, 1999). 
Once released, ATP then acts on specific receptors or is rapidly metabolised by a group 
of ecto-enzymes (Zimmermann, 2000) to products including ADP, AMP, and 
adenosine. ATP and its metabolites are potent mediators of vasomotor tone in most 
vascular beds (Kunapuli and Daniel, 1998); however, the mechanism by which it acts is 
yet to be clarified. 
 ATP and other purines activate purinergic (P) receptors to cause their effects in 
blood vessels. The vasodilator actions of ATP are mediated by the activation of P2Y 
receptors located on the endothelium and are caused by the release of endothelial 
derived relaxing factors such as NO and prostacyclin (Boeynaems et al., 2000; Ralevic 
and Burnstock, 1991) or EDHF (Malmsjo et al., 2002; Stanford et al., 2001).  
 P2X receptors are ligand-gated ion channels (Ralevic and Burnstock, 1988). 
Arterial P2X receptors are located on vascular smooth muscle cells (Vulchanova et al., 
1996) and on the endothelium of some vessels (Glass et al., 2002; Hansen et al., 1999; 
Ray et al., 2002; Yamamoto et al., 2000). The vasoconstrictor role of P2X receptors on 
vascular smooth muscle is well studied, although in contrast, the potential role of P2X 
receptors on endothelial cells is not known. Activation of any receptor on endothelial 
cells that leads to elevation of intracellular calcium would almost certainly release 
endothelial derived relaxing factors. Indeed, it has been suggested that P2X receptor 
activation induced vasodilation of the intact mesenteric arterial bed of the rat (Ralevic, 
2002); however, this phenomenon was described as endothelium independent. 
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Definitive studies of endothelial dependence of any ligand are not possible in the intact 
vascular bed because removal of the endothelial layer is technically difficult.   
Thus, in the current study we have used the selective P2X ligand, ,  
methylene ATP (Burnstock and Kennedy, 1985) to investigate its effects on 
vasodilator functions in isolated 2
nd
 order mesenteric vessels from the rat, where the 
endothelium can be removed easily. Some of this work has been published in 
abstract form (Harrington and Mitchell, 2003). 
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Methods  
Male Wistar rats (200 ± 15.4g) were killed by lethal exposure to CO2 followed 
by cervical dislocation. The rats were maintained and killed in accordance with the 
European Community guidelines for the use of experimental animals. 
The entire mesenteric bed was removed using ligatures, and placed into 
physiological salt solution (PSS; composition in mM) NaCl 119, KCl 4.7, CaCl2 2.5, 
MgSO4 1.17, NaHCO3 25, KH2PO4 1.18, EDTA 0.027, and Glucose 5.5. The 
mesentery was pinned flat on a dissecting dish containing PSS, to allow 2
nd
 order 
arteries to be cleaned of fat and connective tissue; these arteries were stored in fresh 
PSS solution at room temperature until use. In this study, the second order arteries had 
a mean internal diameter of 247µm. 
 
Isometric myograph recordings 
Using tungsten wire, segments of 2mm length of artery were mounted in a four 
channel Mulvany-Halpern myograph (Model 610M, Danish Myo Technology, Aarhus, 
Denmark). The vessels were equilibrated to 37
o
C and the solution bubbled with 95% O2 
and 5% CO2 for 30 minutes. The tension of the vessel was normalised to a tension 
equivalent to that generated at 90% of the diameter of the vessel at 100mmHg, using 
standard procedures as described previously (Mulvany and Halpern, 1977). Changes in 
arterial tone were recorded via a PowerLab/800 recording unit (ADI instruments Pty 
Ltd., Australia), and analysed using Chart 4.0 acquisition system (ADI instruments) on 
a Macintosh personal computer. 
In order to assess the viability of the vessels, they were challenged 3 times with 
high potassium solution (KPSS; PSS with the NaCl replaced by 123.7mM KCl). 
Tissues were then pre-contracted with 10
-5
M methoxamine, and once a plateau was 
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reached 10
-5
M acetylcholine was added to the organ bath. Vessels which relaxed >80% 
in response to acetylcholine were considered to have an intact endothelium. 
Occasionally vessels failed this test and were disregarded.   
 
Drug treatments 
Vessels were contracted to approximately 80% of the response obtained with 
KPSS using methoxamine (10
-5
M) and the effects of single additions of either ATP, 
(10
-4
M), or ,  methylene ATP (10-6M to 10-4M) were determined. At the end of each 
experiment, the ability of the tissue to dilate maximally was determined by the addition 
of sodium nitroprusside (10
-5
M). Since ,  methylene ATP induced a constrictor 
response prior to vasodilation, concentration response curves were constructed using 
single concentrations on individual tissues, and were therefore not cumulative. 
 
In some experiments the nitric oxide synthase inhibitor, L-N
G 
nitro-L-arginine 
(L-NAME; 10
-3
M), the cyclo-oxygenase inhibitor indomethacin (10
-5
M), or apamin 
(5x10
-7
M) plus charybdotoxin (10
-7
M), which together inhibit EDHF responses were 
added. All inhibitors were added 30 mins prior to the addition of methoxamine. 
 
In some experiments, the endothelial layer lining the lumen of the vessels was 
removed physically using a human hair. Complete endothelial removal was 
documented by an absence in the ability of acetylcholine to induce relaxation of vessels 
contracted with methoxamine. 
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Data and statistical analysis 
Contractile or relaxant responses were calculated as a percentage of 
methoxamine induced tone. Data are given as the mean ± s.e.m. for n= 3-8 experiments. 
Data was analysed statistically using one way analysis of variance followed by a 
Dunnett's Multiple Comparison Test, using Prism 4.0. A p value of less than 0.05 was 
considered statistically significant. 
 
 
Drugs 
All drugs were purchased from Sigma Chemical Co. Gillingham, Dorset, UK. 
Drugs were prepared each day, except for , , methylene ATP, charybdotoxin and 
apamin, which were prepared in high concentration ‘stock’ solutions and were stored at 
-20
o
C until used. All drugs were dissolved in aqueous solutions except for 
indomethacin, which was dissolved in dimethyl sulphoxide (DMSO).  
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Results 
P2X receptor ligands induce vasodilation of methoxamine contracted mesenteric 
vessels. 
Profound relaxation of methoxamine contracted vessels was induced by 10
-5
M 
acetylcholine, 10
-4
M ATP, 10
-4
M ,  methylene ATP or 10-5M sodium nitroprusside 
(Figure 1 and Figure 2). In contrast to acetylcholine or sodium nitroprusside, both ATP 
or ,  methylene ATP induced contractile responses prior to vasodilation (Figure 1). 
Interestingly, the vasodilator response induced by either ATP or ,  methylene ATP 
was slower in onset than that induced by acetylcholine. 
 
Characterisation of P2X mediated response  
The vasodilator actions of ,  methylene ATP were concentration dependent. ,  
methylene ATP had an apparent EC50 of approximately 10
-6
M (figure 3). By contrast, 
the contractile actions of ,  methylene ATP were not concentration related in the 
range used in this study (figure 4). 
The vasodilator actions of ,  methylene ATP (10-4M) were not inhibited by 
the combination of L-NAME plus indomethacin. However, dilator responses were 
inhibited by high K
+
 or the combination of charybdotoxin plus apamin and abolished by 
the combination of L-NAME, indomethacin, charybdotoxin, and apamin (Figure 5). 
The dilator actions of ,  methylene ATP were abolished when mesenteric vessels 
were denuded of endothelium (figure 6 and figure 7). By contrast, the constrictor 
actions of ,  methylene ATP were unaffected by endothelial removal, see Figure 8.  
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Discussion 
P2X receptors have been firmly linked to vasoconstrictor function. Where a 
dilator action of P2X receptors have been investigated, this phenomenon was attributed 
to a functional rebound effect of contraction and suggested to be endothelium 
independent. However, we show here for the first time, that the P2X receptor ligand , 
 methylene ATP induces vasodilation, which is endothelium dependent. Furthermore 
we show that the vasodilator actions of ,  methylene ATP are not directly linked to 
the constrictor function as suggested by others (Ralevic, 2002).  
We have previously shown that ATP induces three phases of vascular response 
in the perfused intact mesenteric bed of the rat (Stanford and Mitchell, 1998). ATP 
initially induces a transient dilation mediated by the co-release of NO and prostacyclin, 
which is followed by a constrictor response and finally a sustained dilation, which is 
slow in onset and mediated by EDHF (Stanford et al., 2001). Interestingly, there is a 
clear demarcation of vascular response associated with concentration range of ATP 
used. Thus, at lower concentrations, there is no constrictor response. At doses of 10
-7
 
moles or above ATP induced vasoconstriction followed by the two phases on dilation 
(Mitchell and Stanford, 1998). Thus, the constrictor and second phase dilation induced 
by ATP coincide in the same dose range. This observation clearly demonstrates that a 
common receptor may be involved in both the constrictor and the second phase dilator 
response induced by ATP.  
From our previous work with ATP in the perfused mesenteric bed of the rat, it 
was suggested that P2X receptor activation could result in vasodilation. In the current 
study we have indeed established this to be the case. In fact, ,  methylene ATP 
induces vasoconstriction followed by a profound and sustained dilation, similar in 
nature to the second phase dilator response induced by ATP in the intact arterial 
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mesenteric bed (Stanford and Mitchell, 1998). We found this response to be inhibited 
by high potassium and by the combination of apamin plus charybdotoxin and was 
absent in tissues where the endothelium had been removed. This pharmacological 
profile of results is consistent with EDHF being the mediator responsible for the P2X 
induced vasodilation. 
,  methylene ATP is a selective ligand for  both P2X1 and P2X3 subunits 
(North, 2002; Surprenant et al., 2000). However, two pieces of recently published 
evidence suggest that P2X1 seems the most likely receptor responsible for the 
responses we observed. Firstly, P2X1 immunoreactivity is localised on the 
endothelial as well as the smooth muscle cell layer of blood vessels (Hansen et al., 
1999) and secondly, the vasoconstrictor actions of ,  methylene ATP in 
mesenteric vessels is ascribed solely to activation of P2X1 receptors (Lewis and 
Evans, 2000).  
 Thus, in summary, we have shown, for the first time, that the P2X1 receptor 
ligand ,  methylene ATP is an endothelium-dependent vasodilator of rat isolated 
mesenteric vessels and that EDHF is the predominate mediator involved. This work 
illustrates a novel bi-functional role for P2X receptors, causing constriction when 
activated on smooth muscle and dilation when activated on the endothelium. This 
would be comparable to the variable functions of P2Y receptors, which mediate 
relaxation when located on the endothelium and contraction when situated on the 
smooth muscle cells (Ralevic and Burnstock, 1998).  
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Figures 
 
Figure 1. Representative recorder traces of vasodilator responses of rat mesenteric 
arteries induced by 10
-4
M ATP, 10
-4
M ,  methylene ATP, 10-5M acetylcholine or 10-
5
M sodium nitroprusside (SNP). Vessels were first contracted with 10
-5
M 
methoxamine.  
   
Figure 2. Histogram depicting vasodilation of rat mesenteric arteries induced 10
-4
M 
ATP, 10
-4
M ,  methylene ATP (, ), 10-5M acetylcholine (ACh) or 10-5M sodium 
nitroprusside (SNP). Vessels were first contracted using methoxamine (meth.). The 
natural drift in induced tone which occurs over time is depicted in the column for ‘time 
control’ (T.Con). Results are the mean +/- the S.E. mean (n=3-8). Statistical differences 
were calculated using one-way ANOVA followed by Dunnett’s Multiple Comparison. 
Differences were considered statistical significant where p was found to be <0.05 and 
where p<0.001 *** is shown.  
 
Figure 3. Concentration response curve illustrating the vasodilator effects of ,  
methylene ATP. Isolated mesenteric vessels were contracted with methoxamine 
(meth.). The data shown is the mean +/- the S.E. mean for n=3-4 experiments. In these 
experiments a single concentration was administered to each tissue, cumulative 
response curves were not possible because of desensitisation of the drug. 
 
Figure 4. Effects of ,  methylene ATP on contractile responses of mesenteric vessels 
precontracted with methoxamine (meth.). The concentrations shown are selected from 
 12 
those depicted in Figure 3 where concentration dependent dilation is seen. The data 
shown is the mean +/- the S.E. mean for n=3-4 experiments. Again, a single 
concentration of ,  methylene ATP was administered to each tissue, since cumulative 
response curves were not possible due to desensitisation effect of the drug. 
 
Figure 5. Characterisation of the dilator function of ,  methylene ATP. The figure 
shows the effects of the combination of L-NAME (10
-4
M) plus indomethacin (10
-5
M; 
L+I), apamin (10
-6
M) plus charybdotoxin (10
-7
M; A+C), L+I plus A+C (L/I/A/C) or 
KCl (10
-2
M) on the vasodilator actions of ,  methylene ATP (10-4M) on 
methoxamine (meth.) precontracted arteries. Data is shown as the mean ± s.e.m. for 
n=3-8 experiments. Statistical significance was established using one-way ANOVA 
followed by Dunnetts Multiple Comparison Test. p<0.001; *p<0.05, ***p<0.001.   
 
Figure 6. Role of the endothelium in the vasodilator actions of ,  methylene ATP. 
The figure shows data where responses were obtained using endothelial cell intact 
(+EC) versus endothelial denuded (-EC) arteries precontracted with methoxamine 
(meth.), compared to time controls (T.Con.) Data is shown as the mean ± s.e.m. for 
n=3-8 experiments. Statistical significance was established using one-way ANOVA 
followed by Dunnetts Multiple Comparison Test. p<0.001; *p<0.05, ***p<0.001.   
 
Figure 7. Representative recording of the effect of removal of endothelial cells (+/-EC) 
on ,  methylene ATP vasodilation.  
 
Figure 8. Effect of removal of endothelial cells (+/-EC) on ,  methylene ATP 
contraction in methoxamine (meth.) precontracted mesenteric arteries. Data is shown as 
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the mean ± s.e.m. for n=3-8 experiments. Significant by one-way ANOVA; p<0.001, 
***p<0.001 by Dunnetts Multiple Comparison Test. 
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